Is Harmony Biosciences Holdings, Inc. overvalued?

Harmony Biosciences Holdings, Inc. (HRMY) looks fairly valued — trading about 3% above its fair value.

Fairly valued

Price

$38.12

Fair value

$36.97

Current P/E

15.4

Normal P/E

14.9

Market cap

$2.21B

Dividend yield

0.0%

Return on equity

20.1%

Sector

Healthcare

Fair value compares HRMY's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks